Staphylococcus lysin (Phagelux/Shanghai Pharmaceutical New Asia Medicine)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameStaphylococcus lysin (Phagelux/Shanghai Pharmaceutical New Asia Medicine)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesPhagelux Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPhagelux IncShanghai Xinxianfeng Huakang Medicine Co Ltd
Active IndicationsN/A
Inactive IndicationsStaphylococcal Infections

Other Information

ATC CodeN/A
Related LinksN/A